Algernon Pharmaceuticals Stock Price on January 2, 2025
| AGNPF Stock | USD 0.06 0.01 19.05% |
If you're considering investing in Algernon OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Algernon Pharmaceuticals stands at 0.06, as last reported on the 9th of March, with the highest price reaching 0.06 and the lowest price hitting 0.06 during the day. Algernon Pharmaceuticals appears to be out of control, given 3 months investment horizon. Algernon Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0686, which signifies that the company had a 0.0686 % return per unit of standard deviation over the last 3 months. By analyzing Algernon Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please makes use of Algernon Pharmaceuticals' risk adjusted performance of 0.0479, and Mean Deviation of 5.68 to double-check if our risk estimates are consistent with your expectations.
Algernon OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Algernon |
Sharpe Ratio = 0.0686
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AGNPF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.26 actual daily | 73 73% of assets are less volatile |
Expected Return
| 0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Algernon Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Algernon Pharmaceuticals by adding it to a well-diversified portfolio.
Algernon Pharmaceuticals Valuation on January 2, 2025
It is possible to determine the worth of Algernon Pharmaceuticals on a given historical date. On January 2, 2025 Algernon was worth 0.0463 at the beginning of the trading date compared to the closed value of 0.0463. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Algernon Pharmaceuticals otc stock. Still, in general, we apply an absolute valuation method to find Algernon Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Algernon Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Algernon Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.05 | 0.05 | 0.05 | 0.05 | 8,248 | |
01/02/2025 | 0.05 | 0.05 | 0.05 | 0.05 | 1.00 |
| 0.05 | 0.05 | 0.05 | 0.05 | 19,562 |
| Backtest Algernon Pharmaceuticals | | | Algernon Pharmaceuticals History | | | Algernon Pharmaceuticals Valuation | Previous | Next |
Algernon Pharmaceuticals Trading Date Momentum on January 2, 2025
| On January 03 2025 Algernon Pharmaceuticals was traded for 0.05 at the closing time. The highest daily price throughout the period was 0.05 and the lowest price was 0.05 . The daily volume was 19.6 K. The net trading volume on 01/03/2025 added to the next day price rise. The overall trading delta to closing price of the next trading day was 7.99% . The overall trading delta to current closing price is 26.57% . |
Algernon Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Algernon Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Algernon Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Algernon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Algernon Pharmaceuticals OTC Stock history
Algernon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Algernon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Algernon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Algernon Pharmaceuticals stock prices may prove useful in developing a viable investing in Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Algernon Pharmaceuticals is traded on OTC Exchange in the United States.
Algernon Pharmaceuticals OTC Stock Technical Analysis
Algernon Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Algernon Pharmaceuticals Period Price Range
Low | March 9, 2025
| High |
0.00 | 0.00 |
Algernon Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Algernon Pharmaceuticals March 9, 2025 Market Strength
Market strength indicators help investors to evaluate how Algernon Pharmaceuticals otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Algernon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Algernon Pharmaceuticals otc stock market strength indicators, traders can identify Algernon Pharmaceuticals entry and exit signals to maximize returns
Algernon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Algernon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Algernon OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Algernon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0479 | |||
| Jensen Alpha | 0.6035 | |||
| Total Risk Alpha | 1.18 | |||
| Sortino Ratio | 0.0467 | |||
| Treynor Ratio | 0.1411 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Algernon OTC Stock analysis
When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |